Epitope mapping of commercial antibodies that detect myocilin

Athéna C. Patterson-Orazem, Shannon E. Hill, Michael P. Fautsch, Raquel L. Lieberman

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


The presence of myocilin is often used in the process of validating trabecular meshwork (TM) cells and eye tissues, but the antibody reagents used for detection are poorly characterized. Indeed, for over a century, researchers have been using antibodies to track proteins of interest in a variety of biological contexts, but many antibodies remain ill-defined at the molecular level and in their target epitope. Such issues have prompted efforts from major funding agencies to validate reagents and combat reproducibility issues across biomedical sciences. Here we characterize the epitopes recognized by four commercial myocilin antibodies, aided by structurally and biochemically characterized myocilin fragments. All four antibodies recognize enriched myocilin secreted from human TM cell media. The detection of myocilin fragments by ELISA and Western blot reveal a variety of epitopes across the myocilin polypeptide chain. A more precise understanding of myocilin antibody targets, including conformational specificity, should aid the community in standardizing protocols across laboratories and in turn, lead to a better understanding of eye physiology and disease.

Original languageEnglish (US)
Pages (from-to)109-112
Number of pages4
JournalExperimental Eye Research
StatePublished - Aug 2018


  • Antibodies
  • Antigen
  • Epitopes
  • Glaucoma
  • Myocilin
  • Trabecular meshwork
  • Western blot

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience


Dive into the research topics of 'Epitope mapping of commercial antibodies that detect myocilin'. Together they form a unique fingerprint.

Cite this